STERIS plc Financing Cash Flow
STERIS plc (STE) reported Financing Cash Flow of -$213.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-07
- STERIS plc net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$213.50M.
- STERIS plc net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$97.90M.
- STERIS plc net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$98.00M.
- STERIS plc net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$159.20M.
- STERIS plc net cash provided by (used in) financing activities for fiscal 2026 was -$568.20M.
- STERIS plc net cash provided by (used in) financing activities for fiscal 2025 was -$1.57B.
- STERIS plc net cash provided by (used in) financing activities for fiscal 2024 was -$85.20M.
- STERIS plc net cash provided by (used in) financing activities for fiscal 2023 was -$498.72M, a 530.56% decline from fiscal 2022.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$213.50M 10-Q · filed 2026-08-07 | -$311.40M derived: sum of 2 quarters · filed 2026-08-07 | -$409.40M derived: sum of 3 quarters · filed 2026-08-07 | -$568.60M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | -$97.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | -$195.90M derived: sum of 2 quarters · filed 2026-05-29 | -$355.10M derived: sum of 3 quarters · filed 2026-05-29 | -$568.20M 10-K · filed 2026-05-29 | ||||
| 2025-12-31 | -$98.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06 | -$257.20M derived: sum of 2 quarters · filed 2026-02-06 | -$470.30M 10-Q · filed 2026-02-06 | -$648.40M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-09-30 | -$159.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | -$372.30M 10-Q · filed 2025-11-06 | -$550.40M derived: sum of 3 quarters · filed 2026-08-07 | -$764.80M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | -$213.10M 10-Q · filed 2026-08-07 | -$391.20M derived: sum of 2 quarters · filed 2026-08-07 | -$605.60M derived: sum of 3 quarters · filed 2026-08-07 | -$786.60M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | -$178.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | -$392.50M derived: sum of 2 quarters · filed 2026-05-29 | -$573.50M derived: sum of 3 quarters · filed 2026-05-29 | -$1.57B 10-K · filed 2026-05-29 | -$1.57B 10-K · filed 2025-05-29 | |||
| 2024-12-31 | -$214.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06 | -$395.40M derived: sum of 2 quarters · filed 2026-02-06 | -$1.39B 10-Q · filed 2026-02-06 | -$1.39B 10-Q · filed 2025-02-07 | -$1.54B derived: sum of 4 quarters · filed 2026-05-29 | |||
| 2024-09-30 | -$181.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | -$1.18B 10-Q · filed 2025-11-06 | -$1.18B 10-Q · filed 2024-11-07 | -$1.32B derived: sum of 3 quarters · filed 2026-05-29 | -$1.52B derived: sum of 4 quarters · filed 2026-05-29 | |||
| 2024-06-30 | -$998.90M 10-Q · filed 2025-08-07 | -$998.93M 10-Q · filed 2024-08-08 | -$1.14B derived: sum of 2 quarters · filed 2026-05-29 | -$1.34B derived: sum of 3 quarters · filed 2026-05-29 | -$870.46M derived: sum of 4 quarters · filed 2026-05-29 | |||
| 2024-03-31 | -$143.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | -$341.78M derived: sum of 2 quarters · filed 2026-05-29 | $128.44M derived: sum of 3 quarters · filed 2026-05-29 | -$85.20M 10-K · filed 2026-05-29 | -$85.19M 10-K · filed 2024-05-29 | |||
| 2023-12-31 | -$197.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-07 | $272.22M derived: sum of 2 quarters · filed 2025-02-07 | $58.58M 10-Q · filed 2025-02-07 | -$133.36M derived: sum of 4 quarters · filed 2025-05-29 | ||||
| 2023-09-30 | $470.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | $256.58M 10-Q · filed 2024-11-07 | $64.63M derived: sum of 3 quarters · filed 2025-05-29 | -$55.78M derived: sum of 4 quarters · filed 2025-05-29 | ||||
| 2023-06-30 | -$213.64M 10-Q · filed 2024-08-08 | -$405.58M derived: sum of 2 quarters · filed 2025-05-29 | -$525.99M derived: sum of 3 quarters · filed 2025-05-29 | -$570.94M derived: sum of 4 quarters · filed 2025-05-29 | ||||
| 2023-03-31 | -$191.95M derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-29 | -$312.36M derived: sum of 2 quarters · filed 2025-05-29 | -$357.30M derived: sum of 3 quarters · filed 2025-05-29 | -$498.72M 10-K · filed 2025-05-29 | ||||
| 2022-12-31 | -$120.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08 | -$165.36M derived: sum of 2 quarters · filed 2024-02-08 | -$306.77M 10-Q · filed 2024-02-08 | -$581.38M derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-09-30 | -$44.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-07 | -$186.36M 10-Q · filed 2023-11-07 | -$460.97M derived: sum of 3 quarters · filed 2024-05-29 | -$650.24M derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-06-30 | -$141.41M 10-Q · filed 2023-08-08 | -$416.02M derived: sum of 2 quarters · filed 2024-05-29 | -$605.29M derived: sum of 3 quarters · filed 2024-05-29 | -$844.39M derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-03-31 | -$274.61M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-29 | -$463.87M derived: sum of 2 quarters · filed 2024-05-29 | -$702.98M derived: sum of 3 quarters · filed 2024-05-29 | $115.83M 10-K · filed 2024-05-29 | ||||
| 2021-12-31 | -$189.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-08 | -$428.37M derived: sum of 2 quarters · filed 2023-02-08 | $390.44M 10-Q · filed 2023-02-08 | $293.52M derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-09-30 | -$239.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-09 | $579.70M 10-Q · filed 2022-11-09 | $482.79M derived: sum of 3 quarters · filed 2023-05-26 | $1.12B derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-06-30 | $818.81M 10-Q · filed 2022-08-08 | $721.90M derived: sum of 2 quarters · filed 2023-05-26 | $1.36B derived: sum of 3 quarters · filed 2023-05-26 | $1.30B derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-03-31 | -$96.91M derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-26 | $544.94M derived: sum of 2 quarters · filed 2023-05-26 | $479.62M derived: sum of 3 quarters · filed 2023-05-26 | $345.62M 10-K · filed 2023-05-26 | ||||
| 2020-12-31 | $641.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-09 | $576.53M derived: sum of 2 quarters · filed 2022-02-09 | $442.53M 10-Q · filed 2022-02-09 | $433.26M derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-09-30 | -$65.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-08 | -$199.32M 10-Q · filed 2021-11-08 | -$208.59M derived: sum of 3 quarters · filed 2022-05-31 | -$298.94M derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-06-30 | -$134.00M 10-Q · filed 2021-08-09 | -$143.27M derived: sum of 2 quarters · filed 2022-05-31 | -$233.62M derived: sum of 3 quarters · filed 2022-05-31 | -$289.54M derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-03-31 | -$9.27M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31 | -$99.62M derived: sum of 2 quarters · filed 2022-05-31 | -$155.54M derived: sum of 3 quarters · filed 2022-05-31 | -$163.15M 10-K · filed 2022-05-31 | ||||
| 2019-12-31 | -$90.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-09 | -$146.27M derived: sum of 2 quarters · filed 2021-02-09 | -$153.87M 10-Q · filed 2021-02-09 | -$264.86M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-09-30 | -$55.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-06 | -$63.53M 10-Q · filed 2020-11-06 | -$174.51M derived: sum of 3 quarters · filed 2021-05-28 | -$218.46M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-06-30 | -$7.61M 10-Q · filed 2020-08-07 | -$118.59M derived: sum of 2 quarters · filed 2021-05-28 | -$162.54M derived: sum of 3 quarters · filed 2021-05-28 | -$263.19M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-03-31 | -$110.98M derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-28 | -$154.93M derived: sum of 2 quarters · filed 2021-05-28 | -$255.58M derived: sum of 3 quarters · filed 2021-05-28 | -$294.79M 10-K · filed 2021-05-28 | ||||
| 2018-12-31 | -$43.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | -$144.59M derived: sum of 2 quarters · filed 2020-02-10 | -$183.81M 10-Q · filed 2020-02-10 | |||||
| 2018-09-30 | -$100.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-07 | -$139.86M 10-Q · filed 2019-11-07 | ||||||
| 2018-06-30 | -$39.21M 10-Q · filed 2019-08-07 | |||||||
| 2018-03-31 | -$356.18M 8-K · filed 2021-02-09 | |||||||
| 2017-03-31 | -$267.10M 10-K · filed 2019-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |